nodes	percent_of_prediction	percent_of_DWPC	metapath
Agomelatine—CYP1A2—Carmustine—lymphatic system cancer	0.361	0.623	CbGbCtD
Agomelatine—CYP2C9—Teniposide—lymphatic system cancer	0.219	0.377	CbGbCtD
Agomelatine—Depression—Mechlorethamine—lymphatic system cancer	0.00954	0.0227	CcSEcCtD
Agomelatine—Jaundice—Mechlorethamine—lymphatic system cancer	0.00933	0.0222	CcSEcCtD
Agomelatine—Aggression—Bleomycin—lymphatic system cancer	0.00925	0.022	CcSEcCtD
Agomelatine—Hepatic failure—Fludarabine—lymphatic system cancer	0.00895	0.0213	CcSEcCtD
Agomelatine—Tinnitus—Mechlorethamine—lymphatic system cancer	0.00801	0.0191	CcSEcCtD
Agomelatine—Vertigo—Mechlorethamine—lymphatic system cancer	0.00672	0.016	CcSEcCtD
Agomelatine—Unspecified disorder of skin and subcutaneous tissue—Mechlorethamine—lymphatic system cancer	0.00632	0.0151	CcSEcCtD
Agomelatine—Infection—Mechlorethamine—lymphatic system cancer	0.00606	0.0144	CcSEcCtD
Agomelatine—Skin disorder—Mechlorethamine—lymphatic system cancer	0.00593	0.0141	CcSEcCtD
Agomelatine—Hepatic failure—Vincristine—lymphatic system cancer	0.00547	0.013	CcSEcCtD
Agomelatine—Agitation—Teniposide—lymphatic system cancer	0.00507	0.0121	CcSEcCtD
Agomelatine—Face oedema—Carmustine—lymphatic system cancer	0.00497	0.0118	CcSEcCtD
Agomelatine—Weight decreased—Bleomycin—lymphatic system cancer	0.00461	0.011	CcSEcCtD
Agomelatine—Infection—Teniposide—lymphatic system cancer	0.00447	0.0106	CcSEcCtD
Agomelatine—Agitation—Fludarabine—lymphatic system cancer	0.00445	0.0106	CcSEcCtD
Agomelatine—Hyperhidrosis—Teniposide—lymphatic system cancer	0.00435	0.0104	CcSEcCtD
Agomelatine—Pruritus—Mechlorethamine—lymphatic system cancer	0.00432	0.0103	CcSEcCtD
Agomelatine—Diarrhoea—Mechlorethamine—lymphatic system cancer	0.00417	0.00995	CcSEcCtD
Agomelatine—Depression—Carmustine—lymphatic system cancer	0.00396	0.00943	CcSEcCtD
Agomelatine—Infection—Fludarabine—lymphatic system cancer	0.00393	0.00936	CcSEcCtD
Agomelatine—Vomiting—Mechlorethamine—lymphatic system cancer	0.00388	0.00924	CcSEcCtD
Agomelatine—Nervous system disorder—Fludarabine—lymphatic system cancer	0.00388	0.00924	CcSEcCtD
Agomelatine—Weight decreased—Vincristine—lymphatic system cancer	0.00384	0.00916	CcSEcCtD
Agomelatine—Hyperhidrosis—Fludarabine—lymphatic system cancer	0.00382	0.00911	CcSEcCtD
Agomelatine—Depression—Vincristine—lymphatic system cancer	0.00378	0.009	CcSEcCtD
Agomelatine—Weight increased—Mitoxantrone—lymphatic system cancer	0.00376	0.00897	CcSEcCtD
Agomelatine—Weight decreased—Mitoxantrone—lymphatic system cancer	0.00374	0.00892	CcSEcCtD
Agomelatine—Gastrointestinal pain—Teniposide—lymphatic system cancer	0.00368	0.00876	CcSEcCtD
Agomelatine—Nausea—Mechlorethamine—lymphatic system cancer	0.00362	0.00864	CcSEcCtD
Agomelatine—Jaundice—Mitoxantrone—lymphatic system cancer	0.0036	0.00857	CcSEcCtD
Agomelatine—Urticaria—Teniposide—lymphatic system cancer	0.00357	0.00851	CcSEcCtD
Agomelatine—Abdominal pain—Teniposide—lymphatic system cancer	0.00356	0.00847	CcSEcCtD
Agomelatine—Paraesthesia—Fludarabine—lymphatic system cancer	0.00355	0.00846	CcSEcCtD
Agomelatine—Hallucination—Carmustine—lymphatic system cancer	0.00354	0.00844	CcSEcCtD
Agomelatine—Connective tissue disorder—Carmustine—lymphatic system cancer	0.0035	0.00834	CcSEcCtD
Agomelatine—Dyspepsia—Fludarabine—lymphatic system cancer	0.00348	0.00829	CcSEcCtD
Agomelatine—Gastrointestinal disorder—Fludarabine—lymphatic system cancer	0.00341	0.00813	CcSEcCtD
Agomelatine—Fatigue—Fludarabine—lymphatic system cancer	0.00341	0.00812	CcSEcCtD
Agomelatine—Hallucination—Vincristine—lymphatic system cancer	0.00338	0.00806	CcSEcCtD
Agomelatine—Constipation—Fludarabine—lymphatic system cancer	0.00338	0.00806	CcSEcCtD
Agomelatine—Connective tissue disorder—Vincristine—lymphatic system cancer	0.00334	0.00796	CcSEcCtD
Agomelatine—Eye disorder—Carmustine—lymphatic system cancer	0.00333	0.00793	CcSEcCtD
Agomelatine—Hepatitis—Mitoxantrone—lymphatic system cancer	0.00331	0.00789	CcSEcCtD
Agomelatine—Asthenia—Teniposide—lymphatic system cancer	0.00323	0.00769	CcSEcCtD
Agomelatine—Pruritus—Teniposide—lymphatic system cancer	0.00318	0.00758	CcSEcCtD
Agomelatine—Mental disorder—Carmustine—lymphatic system cancer	0.00312	0.00743	CcSEcCtD
Agomelatine—Diarrhoea—Teniposide—lymphatic system cancer	0.00308	0.00733	CcSEcCtD
Agomelatine—Back pain—Carmustine—lymphatic system cancer	0.003	0.00715	CcSEcCtD
Agomelatine—Mental disorder—Vincristine—lymphatic system cancer	0.00298	0.0071	CcSEcCtD
Agomelatine—Vision blurred—Carmustine—lymphatic system cancer	0.00292	0.00696	CcSEcCtD
Agomelatine—Tremor—Carmustine—lymphatic system cancer	0.0029	0.00692	CcSEcCtD
Agomelatine—Infection—Bleomycin—lymphatic system cancer	0.00288	0.00686	CcSEcCtD
Agomelatine—Back pain—Vincristine—lymphatic system cancer	0.00286	0.00682	CcSEcCtD
Agomelatine—Vomiting—Teniposide—lymphatic system cancer	0.00286	0.00681	CcSEcCtD
Agomelatine—Agitation—Carmustine—lymphatic system cancer	0.00285	0.00679	CcSEcCtD
Agomelatine—Asthenia—Fludarabine—lymphatic system cancer	0.00284	0.00676	CcSEcCtD
Agomelatine—Headache—Teniposide—lymphatic system cancer	0.00282	0.00671	CcSEcCtD
Agomelatine—Pruritus—Fludarabine—lymphatic system cancer	0.0028	0.00666	CcSEcCtD
Agomelatine—Back pain—Mitoxantrone—lymphatic system cancer	0.00279	0.00664	CcSEcCtD
Agomelatine—Agitation—Vincristine—lymphatic system cancer	0.00272	0.00648	CcSEcCtD
Agomelatine—Vision blurred—Mitoxantrone—lymphatic system cancer	0.00272	0.00647	CcSEcCtD
Agomelatine—Diarrhoea—Fludarabine—lymphatic system cancer	0.00271	0.00645	CcSEcCtD
Agomelatine—Nausea—Teniposide—lymphatic system cancer	0.00267	0.00637	CcSEcCtD
Agomelatine—Vertigo—Vincristine—lymphatic system cancer	0.00266	0.00634	CcSEcCtD
Agomelatine—Hepatic failure—Methotrexate—lymphatic system cancer	0.00265	0.00632	CcSEcCtD
Agomelatine—Anxiety—Carmustine—lymphatic system cancer	0.00263	0.00627	CcSEcCtD
Agomelatine—Paraesthesia—Bleomycin—lymphatic system cancer	0.0026	0.0062	CcSEcCtD
Agomelatine—Infection—Carmustine—lymphatic system cancer	0.00251	0.00599	CcSEcCtD
Agomelatine—Vomiting—Fludarabine—lymphatic system cancer	0.00251	0.00599	CcSEcCtD
Agomelatine—Headache—Fludarabine—lymphatic system cancer	0.00248	0.0059	CcSEcCtD
Agomelatine—Anxiety—Mitoxantrone—lymphatic system cancer	0.00245	0.00583	CcSEcCtD
Agomelatine—Infection—Vincristine—lymphatic system cancer	0.0024	0.00572	CcSEcCtD
Agomelatine—Nervous system disorder—Vincristine—lymphatic system cancer	0.00237	0.00564	CcSEcCtD
Agomelatine—Nausea—Fludarabine—lymphatic system cancer	0.00235	0.0056	CcSEcCtD
Agomelatine—Infection—Mitoxantrone—lymphatic system cancer	0.00234	0.00557	CcSEcCtD
Agomelatine—Hyperhidrosis—Vincristine—lymphatic system cancer	0.00234	0.00556	CcSEcCtD
Agomelatine—Urticaria—Bleomycin—lymphatic system cancer	0.0023	0.00549	CcSEcCtD
Agomelatine—Insomnia—Carmustine—lymphatic system cancer	0.00229	0.00545	CcSEcCtD
Agomelatine—Skin disorder—Mitoxantrone—lymphatic system cancer	0.00228	0.00544	CcSEcCtD
Agomelatine—Irritability—Methotrexate—lymphatic system cancer	0.00228	0.00542	CcSEcCtD
Agomelatine—Hyperhidrosis—Mitoxantrone—lymphatic system cancer	0.00227	0.00542	CcSEcCtD
Agomelatine—Paraesthesia—Carmustine—lymphatic system cancer	0.00227	0.00541	CcSEcCtD
Agomelatine—Somnolence—Carmustine—lymphatic system cancer	0.00225	0.00536	CcSEcCtD
Agomelatine—Insomnia—Vincristine—lymphatic system cancer	0.00218	0.00521	CcSEcCtD
Agomelatine—Gastrointestinal disorder—Carmustine—lymphatic system cancer	0.00218	0.0052	CcSEcCtD
Agomelatine—Paraesthesia—Vincristine—lymphatic system cancer	0.00217	0.00517	CcSEcCtD
Agomelatine—Constipation—Carmustine—lymphatic system cancer	0.00216	0.00516	CcSEcCtD
Agomelatine—Paraesthesia—Mitoxantrone—lymphatic system cancer	0.00211	0.00503	CcSEcCtD
Agomelatine—Somnolence—Mitoxantrone—lymphatic system cancer	0.00209	0.00498	CcSEcCtD
Agomelatine—Gastrointestinal disorder—Vincristine—lymphatic system cancer	0.00209	0.00497	CcSEcCtD
Agomelatine—Fatigue—Vincristine—lymphatic system cancer	0.00208	0.00496	CcSEcCtD
Agomelatine—Asthenia—Bleomycin—lymphatic system cancer	0.00208	0.00496	CcSEcCtD
Agomelatine—Dyspepsia—Mitoxantrone—lymphatic system cancer	0.00207	0.00493	CcSEcCtD
Agomelatine—Gastrointestinal pain—Carmustine—lymphatic system cancer	0.00207	0.00493	CcSEcCtD
Agomelatine—Constipation—Vincristine—lymphatic system cancer	0.00207	0.00492	CcSEcCtD
Agomelatine—Pruritus—Bleomycin—lymphatic system cancer	0.00205	0.00489	CcSEcCtD
Agomelatine—Fatigue—Mitoxantrone—lymphatic system cancer	0.00203	0.00483	CcSEcCtD
Agomelatine—Constipation—Mitoxantrone—lymphatic system cancer	0.00201	0.00479	CcSEcCtD
Agomelatine—Abdominal pain—Carmustine—lymphatic system cancer	0.002	0.00477	CcSEcCtD
Agomelatine—Gastrointestinal pain—Vincristine—lymphatic system cancer	0.00198	0.00471	CcSEcCtD
Agomelatine—Gastrointestinal pain—Mitoxantrone—lymphatic system cancer	0.00192	0.00458	CcSEcCtD
Agomelatine—Abdominal pain—Vincristine—lymphatic system cancer	0.00191	0.00455	CcSEcCtD
Agomelatine—Urticaria—Mitoxantrone—lymphatic system cancer	0.00187	0.00445	CcSEcCtD
Agomelatine—Abdominal pain—Mitoxantrone—lymphatic system cancer	0.00186	0.00443	CcSEcCtD
Agomelatine—Vomiting—Bleomycin—lymphatic system cancer	0.00184	0.00439	CcSEcCtD
Agomelatine—Infestation NOS—Methotrexate—lymphatic system cancer	0.00184	0.00438	CcSEcCtD
Agomelatine—Infestation—Methotrexate—lymphatic system cancer	0.00184	0.00438	CcSEcCtD
Agomelatine—Depression—Methotrexate—lymphatic system cancer	0.00183	0.00437	CcSEcCtD
Agomelatine—Asthenia—Carmustine—lymphatic system cancer	0.00182	0.00433	CcSEcCtD
Agomelatine—Hepatobiliary disease—Methotrexate—lymphatic system cancer	0.00174	0.00414	CcSEcCtD
Agomelatine—Asthenia—Vincristine—lymphatic system cancer	0.00173	0.00413	CcSEcCtD
Agomelatine—Diarrhoea—Carmustine—lymphatic system cancer	0.00173	0.00413	CcSEcCtD
Agomelatine—Nausea—Bleomycin—lymphatic system cancer	0.00172	0.0041	CcSEcCtD
Agomelatine—Asthenia—Mitoxantrone—lymphatic system cancer	0.00169	0.00402	CcSEcCtD
Agomelatine—Dizziness—Carmustine—lymphatic system cancer	0.00167	0.00399	CcSEcCtD
Agomelatine—Diarrhoea—Vincristine—lymphatic system cancer	0.00165	0.00394	CcSEcCtD
Agomelatine—Hepatitis—Methotrexate—lymphatic system cancer	0.00165	0.00393	CcSEcCtD
Agomelatine—Diarrhoea—Mitoxantrone—lymphatic system cancer	0.00161	0.00383	CcSEcCtD
Agomelatine—Vomiting—Carmustine—lymphatic system cancer	0.00161	0.00383	CcSEcCtD
Agomelatine—Dizziness—Vincristine—lymphatic system cancer	0.0016	0.00381	CcSEcCtD
Agomelatine—Headache—Carmustine—lymphatic system cancer	0.00159	0.00378	CcSEcCtD
Agomelatine—Eye disorder—Methotrexate—lymphatic system cancer	0.00154	0.00367	CcSEcCtD
Agomelatine—Tinnitus—Methotrexate—lymphatic system cancer	0.00154	0.00366	CcSEcCtD
Agomelatine—Vomiting—Vincristine—lymphatic system cancer	0.00154	0.00366	CcSEcCtD
Agomelatine—Headache—Vincristine—lymphatic system cancer	0.00151	0.00361	CcSEcCtD
Agomelatine—Nausea—Carmustine—lymphatic system cancer	0.0015	0.00358	CcSEcCtD
Agomelatine—Vomiting—Mitoxantrone—lymphatic system cancer	0.0015	0.00356	CcSEcCtD
Agomelatine—Headache—Mitoxantrone—lymphatic system cancer	0.00147	0.00351	CcSEcCtD
Agomelatine—Mental disorder—Methotrexate—lymphatic system cancer	0.00145	0.00344	CcSEcCtD
Agomelatine—Nausea—Vincristine—lymphatic system cancer	0.00143	0.00342	CcSEcCtD
Agomelatine—Nausea—Mitoxantrone—lymphatic system cancer	0.0014	0.00333	CcSEcCtD
Agomelatine—Back pain—Methotrexate—lymphatic system cancer	0.00139	0.00331	CcSEcCtD
Agomelatine—Vision blurred—Methotrexate—lymphatic system cancer	0.00135	0.00322	CcSEcCtD
Agomelatine—Vertigo—Methotrexate—lymphatic system cancer	0.00129	0.00307	CcSEcCtD
Agomelatine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—lymphatic system cancer	0.00121	0.00289	CcSEcCtD
Agomelatine—Infection—Methotrexate—lymphatic system cancer	0.00116	0.00277	CcSEcCtD
Agomelatine—Nervous system disorder—Methotrexate—lymphatic system cancer	0.00115	0.00274	CcSEcCtD
Agomelatine—Skin disorder—Methotrexate—lymphatic system cancer	0.00114	0.00271	CcSEcCtD
Agomelatine—Hyperhidrosis—Methotrexate—lymphatic system cancer	0.00113	0.0027	CcSEcCtD
Agomelatine—Insomnia—Methotrexate—lymphatic system cancer	0.00106	0.00253	CcSEcCtD
Agomelatine—Paraesthesia—Methotrexate—lymphatic system cancer	0.00105	0.00251	CcSEcCtD
Agomelatine—Somnolence—Methotrexate—lymphatic system cancer	0.00104	0.00248	CcSEcCtD
Agomelatine—Dyspepsia—Methotrexate—lymphatic system cancer	0.00103	0.00246	CcSEcCtD
Agomelatine—Gastrointestinal disorder—Methotrexate—lymphatic system cancer	0.00101	0.00241	CcSEcCtD
Agomelatine—Fatigue—Methotrexate—lymphatic system cancer	0.00101	0.00241	CcSEcCtD
Agomelatine—Gastrointestinal pain—Methotrexate—lymphatic system cancer	0.000958	0.00228	CcSEcCtD
Agomelatine—Urticaria—Methotrexate—lymphatic system cancer	0.000931	0.00222	CcSEcCtD
Agomelatine—Abdominal pain—Methotrexate—lymphatic system cancer	0.000926	0.00221	CcSEcCtD
Agomelatine—Asthenia—Methotrexate—lymphatic system cancer	0.000841	0.002	CcSEcCtD
Agomelatine—Pruritus—Methotrexate—lymphatic system cancer	0.000829	0.00198	CcSEcCtD
Agomelatine—Diarrhoea—Methotrexate—lymphatic system cancer	0.000802	0.00191	CcSEcCtD
Agomelatine—Dizziness—Methotrexate—lymphatic system cancer	0.000775	0.00185	CcSEcCtD
Agomelatine—Vomiting—Methotrexate—lymphatic system cancer	0.000745	0.00178	CcSEcCtD
Agomelatine—Headache—Methotrexate—lymphatic system cancer	0.000734	0.00175	CcSEcCtD
Agomelatine—Nausea—Methotrexate—lymphatic system cancer	0.000696	0.00166	CcSEcCtD
